ACRS profile · all as-reported value updates
Aclaris Therapeutics, Inc. (ACRS) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2018 | 10,091,000 | 6,151,000 | -3,940,000 | -39.04% | revised comparative figure | 0001558370-19-002211 0001558370-21-001717 | 3 filed observations examined for this concept and period. |
| Operating income | 2018 | -135,414,000 | -84,780,000 | 50,634,000 | +37.39% | revised comparative figure | 0001558370-19-002211 0001558370-21-001717 | 3 filed observations examined for this concept and period. |
| Operating income | 2017 | -72,423,000 | -54,361,000 | 18,062,000 | +24.94% | revised comparative figure | 0001558370-18-001866 0001558370-20-001325 | 3 filed observations examined for this concept and period. |